Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.

A draft of RFK Jr.'s much-awaited strategy for a healthier America softens rhetoric on agricultural chemicals and stresses ...

In RFK Jr.’s America, it will never be safe to practice public health or medicine," write an epidemiologist and a former CDC ...

Morning. Today, we see march-in rights return to the headlines, ponder how Eli Lilly’s plan to hike list prices in Europe may ...

When U.S. regulators aren’t in the room while global standards are written, the future of patient safety, medical innovation, and cybersecurity are at risk.

Eli Lilly plans to increase prices of medicines in Europe and other developed markets “in order to make them lower” in the ...

A record-low number of Americans are drinking, according to a new Gallup poll that has been tracking this data since 1939.

Last November, in the days following Donald Trump’s election, leaders at the National Institutes of Health began discussing ...

With U.S. funding for science at risk, a longtime advocate sees ‘light at the end of the tunnel’ in Washington.